Search

Christopher V Larka

from Cincinnati, OH
Age ~59
Get Report
Also known as:
Christopher J Larka, Christophe V Larka, Chris V Larka, Christoph Larka, Barbara Larka
Phone and address:
900 Meadow Ridge Dr, Cincinnati, OH 45245
(513) 943-7609
Related to:
Bruce Larka, 56Angela G Graf, 47Barbara A Gard, 80Annette Reichard, 58Todd Graf, 51
Connected to:
John R Larka, 78Conrad Larkai, 41Donald W Larke, 102Heidi Larke, 55Joan F Larke, 89Joseph E Larke, 86Karen J Larke, 36Tiffany Larke, 45Benjamin Larkey, 50

Christopher Larka Phones & Addresses

  • 900 Meadow Ridge Dr, Withamsville, OH 45245 (513) 943-7609
  • Cincinnati, OH
  • Batavia, OH

Resumes

Resumes

Christopher Larka Photo 1

Scientist Ii

View page
Location:
Cincinnati, OH
Industry:
Biotechnology
Work:
Meridian Bioscience Inc.
Scientist Ii
Education:
Xavier University (Ph) Sep 1991 - 1995
Master of Business Administration, Masters, Business Edinboro University of Pennsylvania Sep 1987 - 1989
Master of Science, Masters, Biology Indiana University of Pennsylvania Sep 1984 - 1987
Bachelors, Bachelor of Science, Biology
Skills:
Immunoassays
Protein Purification
Elisa
Cell Culture
Antibodies
Purification
R&D
Western Blotting
Medical Devices
Biotechnology
Sds Page
Gmp
Manufacturing
Fda
Life Sciences
Pharmaceutical Industry
Lateral Flow Assays
Fermentation
Immunology
Antibody Purification
Coupling Chemistries
Sds Page and Western Blots
Characterization of Proteins
Bacterial and Cell Culture
Gmp/Iso
Colloidal Gold Technology
Basic Fermentation
Microbiology
Sop
Cross Functional Team Leadership
Characterization
Validation
Biochemistry
Christopher Larka Photo 2

Scientist At Meridian Bioscience, Inc

View page
Location:
Cincinnati Area
Industry:
Biotechnology

Publications

Us Patents

Immunoassay For H. Pylori In Fecal Specimens

View page
US Patent:
RE38088, Apr 22, 2003
Filed:
Feb 8, 2000
Appl. No.:
09/500365
Inventors:
Christopher Vance Larka - Cincinnati OH
Ching Sui Arthur Yi - Cincinnati OH
Kenneth James Kozak - Cincinnati OH
Assignee:
Meridian Bioscience, Inc. - Cincinnati OH
International Classification:
G01N 33554
US Classification:
435 732, 4352521, 435 6, 435 12, 436 66
Abstract:
A process for the determination of H. Pylori in a fecal specimen comprising (a) dispersing a fecal specimen suspected of carrying H. pylori in a sample diluent; (b) contacting the fecal specimen in the diluent with a first polyclonal antibody for H. pylori antigen to form a complex of the antibody and the antigen; (c) separating said specimen and said complex; (d) exposing the complex to a second polyclonal antibody for said antigen and a portion of the antibody reacting with said complex, one of said first and second antibody being bound to a solid carrier and the other being labeled with a detecting agent; and (e) determining the amount of the labeled antibody and in turn determining the presence of H. pylori antigen in said fecal specimen.

Immunoassay For H. Pylori In Fecal Specimens

View page
US Patent:
59324309, Aug 3, 1999
Filed:
Mar 10, 1998
Appl. No.:
9/037894
Inventors:
Christopher Vance Larka - Cincinnati OH
Ching Sui Arthur Yi - Cincinnati OH
Kenneth James Kozak - Cincinnati OH
Assignee:
Meridian Diagnostics, Inc. - Cincinnati OH
International Classification:
G01N 33554
G01N 33569
US Classification:
435 732
Abstract:
A process for the determination of H. pylori in a fecal specimen comprising (a) dispersing a fecal specimen suspected of carrying H. pylori in a sample diluent; (b) contacting the fecal specimen in the diluent with a first polyclonal antibody for H. pylori antigen to form a complex of the antibody and the antigen; (c) separating said specimen and said complex; (d) exposing the complex to a second polyclonal antibody for said antigen and a portion of the antibody reacting with said complex, one of said first and second antibody being bound to a solid carrier and the other being labeled with a detection agent; and (e) determining the amount of the labeled antibody and in turn determining the presence of H. pylori antigen in said fecal specimen.

Immunoassay For H. Pylori In Fecal Specimens

View page
US Patent:
58719423, Feb 16, 1999
Filed:
Jul 21, 1997
Appl. No.:
8/897732
Inventors:
Christopher Vance Larka - Cincinnati OH
Ching Sui Arthur Yi - Cincinnati OH
Kenneth James Kozak - Cincinnati OH
Assignee:
Meridian Diagnostics, Inc. - Cincinnati OH
International Classification:
G01N 33554
G01N 33569
US Classification:
435 732
Abstract:
A process for the determination of H. pylori in a fecal specimen which comprises; (a) collecting a smear of a fecal specimen on a substrate; (b) immersing at least the portion of the substrate carrying the smear in a sample diluent so as to disperse the fecal specimen in the diluent; (c) contacting the fecal specimen in the diluent with a first polyclonal antibody for H. pylori antigen to form a complex of the antibody and the antigen; (d) separating the specimen and the complex; (e) exposing the complex to a second polyclonal antibody for the antigen and a portion of the antibody reacting with the complex, one of said first and second antibody being bound to a solid carrier and the other being labelled with a detection agent; and (f) determining the amount of the labelled antibody and in turn determining the presence of H. pylori antigen in the fecal specimen.

Immunoassay For H. Pylori In Fecal Specimens

View page
US Patent:
57167915, Feb 10, 1998
Filed:
May 9, 1996
Appl. No.:
8/647115
Inventors:
Christopher Vance Larka - Cincinnati OH
Ching Sui Arthur Yi - Cincinnati OH
Kenneth James Kozak - Cincinnati OH
Assignee:
Meridian Diagnostics, Inc. - Cincinnati OH
International Classification:
G01N 33554
G01N 33569
US Classification:
435 732
Abstract:
A process for the determination of H. pylori in a fecal specimen comprising (a) dispersing a fecal specimen suspected of carrying H. pylori in a sample diluent; (b) contacting the fecal specimen in the diluent with a first polyclonal antibody for H. pylori antigen to form a complex of the antibody and the antigen; (c) separating said specimen and said complex; (d) exposing the complex to a second polyclonal antibody for said antigen and a portion of the antibody reacting with said complex, one of said first and second antibody being bound to a solid carrier and the other being labeled with a detection agent; and (e) determining the amount of the labeled antibody and in turn determining the presence of H. pylori antigen in said fecal specimen.
Control profile
Christopher V Larka from Cincinnati, OH, age ~59 Get Report